ALNYLAM PHARMACEUTICALS INC

About

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference (RNAi) therapeutics. The company specializes in treating rare, genetically defined diseases by silencing specific genes that cause or contribute to pathological conditions. As a leader in the RNAi space, Alnylam has established a diversified pipeline and multiple FDA-approved products targeting areas such as hereditary ATTR amyloidosis and acute hepatic porphyria.